URGN - UroGen Pharma Ltd - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

URGN is currently covered by 4 analysts with an average price target of $29.35. This is a potential upside of $15.14 (106.54%) from yesterday's end of day stock price of $14.21.

UroGen Pharma Ltd's activity chart (see below) currently has 52 price targets and 45 ratings on display. The stock rating distribution of URGN is 94.12% BUY and 5.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.04% with an average time for these price targets to be met of 50.4 days.

Highest price target for URGN is $54, Lowest price target is $18, average price target is $29.35.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 18-Apr-2024. First documented stock forecast 30-May-2017.

Best performing analysts who are covering URGN - UroGen Pharma Ltd:

Derek Archila Paul Choi Leland Gershell Raghuram Selvaraju Chris Howerton

Currently out of the existing stock ratings of URGN, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

54

$39.63 (275.78%)

54

6 days ago

0/16 (0%)

$39.74 (278.68%)

Buy

35

$20.63 (143.56%)

32

3 months ago

1/13 (7.69%)

$19.96 (132.71%)

74

Hold

18

$3.63 (25.26%)

11

8 months 24 days ago

3/8 (37.5%)

$-3.66 (-16.90%)

80

Buy

10

$-4.37 (-30.41%)

45

1 years 2 months 16 days ago

1/4 (25%)

$0.86 (9.41%)

9

Buy

41

$26.63 (185.32%)

70

4 years 6 months 3 days ago

2/5 (40%)

$18.82 (84.85%)

89

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is URGN (UroGen Pharma Ltd) average time for price targets to be met?

On average it took 50.4 days on average for the stock forecasts to be realized with a an average price target met ratio 22.04

Which analyst has the current highest performing score on URGN (UroGen Pharma Ltd) with a proven track record?

DEREK ARCHILA

Which analyst has the current lower performing score on URGN (UroGen Pharma Ltd) with a proven track record?

CHRIS HOWERTON

Which analyst has the most public recommendations on URGN (UroGen Pharma Ltd)?

Derek Archila works at WELLS FARGO and has 3 price targets and 2 ratings on URGN

Which analyst is the currently most bullish on URGN (UroGen Pharma Ltd)?

Raghuram Selvaraju with highest potential upside - $39.63

Which analyst is the currently most reserved on URGN (UroGen Pharma Ltd)?

Chris Howerton with lowest potential downside - -$4.37

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?